Last reviewed · How we verify
Testosterone Pellets
At a glance
| Generic name | Testosterone Pellets |
|---|---|
| Also known as | Testopel 75 mg testosterone pellets |
| Sponsor | Men's Health Boston |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment (PHASE2)
- Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME) (PHASE3)
- Testopel ® vs. Generic Testosterone Pellets. (PHASE3)
- Does Testosterone Therapy Improve Patient-Reported Outcomes in Age-Related Testosterone Deficient Patients Undergoing Total Hip Replacement: A Randomized-Controlled Trial (PHASE3)
- A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole (PHASE1)
- Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Testosterone Pellets CI brief — competitive landscape report
- Testosterone Pellets updates RSS · CI watch RSS
- Men's Health Boston portfolio CI